BVS
Bioventus·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 0
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
Revenue Beats Expectation
Low Beta
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BVS
Bioventus Inc.
A global leader in innovations for active healing
Life Science Tools and Services
12/22/2015
02/11/2021
NASDAQ Stock Exchange
930
12-31
Common stock
4721 Emperor Boulevard, Suite 400, Durham, North Carolina 27703
--
Bioventis Inc., was incorporated in Delaware on December 22, 2015. Bioventures LLC was incorporated in Delaware on November 23, 2011 as a limited liability company. The company is a global medical device company focused on developing and commercializing clinically differentiated, cost-effective and minimally invasive treatments to participate in and enhance the body's natural healing process.
Earnings Call
Q1/2025
Estimate EPS0.02
Actual EPS0.06
Estimate Revenue122.71M
Actual Revenue123.90M
Bioventus Q1 2025: Contradictions Unveiled on Pain Treatment Trends, Growth Expectations, and Financial Projections
May 06,2025 07:32
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.21
Actual EPS0.21
Estimate Revenue145.86M
Actual Revenue147.70M
Bioventus Q2 2025: Key Contradictions Unveiled on Tariffs, Growth Projections, and Market Dynamics
Aug 06,2025 06:08
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
BVS has released its 2025 Q3 earnings. EPS was reported at 0.15, versus the expected 0.12, beating expectations. The chart below visualizes how BVS has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BVS has released its 2025 Q3 earnings report, with revenue of 138.65M, reflecting a YoY change of -0.23%, and net profit of 4.01M, showing a YoY change of 168.50%. The Sankey diagram below clearly presents BVS's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
